News
Johnson & Johnson hit with $247 million verdict in hip implant trial
Article published by Reuters. Delivering a third straight win to patients, the jury found that the metal-on-metal hip implants were defectively designed and that the companies failed to warn consumers about the risks. Read more here.
Last modified: Tue, 27 Feb 2018 12:16:14 GMT